Antibody response after third BNT162b2 dose in recipients of allogeneic HSCT

被引：71

作者：

Redjoul, Rabah ^{[1
]}

Le Bouter, Anne ^{[2
]}

Parinet, Vincent ^{[1
]}

Fourati, Slim ^{[2
,3
]}

Maury, Sebastien ^{[1
,2
,3
]}

机构：

[1] Henri Mondor Hosp, AP HP, Dept Haematol, F-94000 Creteil, France

[2] Henri Mondor Hosp, AP HP, Dept Virol, F-94000 Creteil, France

[3] Univ Paris Est Creteil Val Marne, INSERM U955, Creteil, France

来源：

LANCET HAEMATOLOGY | 2021年 / 8卷 / 10期

关键词：

COVID-19; OUTCOMES;

D O I：

10.1016/S2352-3026(21)00274-X

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E681 / E683

页数：3

共 10 条

[1] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Ebinger, Joseph E.
Fert-Bober, Justyna
Printsev, Ignat
Wu, Min
Sun, Nancy
Prostko, John C.
Frias, Edwin C.
Stewart, James L.
Van Eyk, Jennifer E.
Braun, Jonathan G.
Cheng, Susan
Sobhani, Kimia
[J]. NATURE MEDICINE, 2021, 27 (06) : 981 - +
[2] Gallais F., MEDRXIV, DOI [DOI 10.1101/2021.05.07.21256823(2021, DOI 10.1101/2021.05.07.21256823, 10.1101/2021.05.07.21256823(2021]
[3] Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
Kamar, Nassim
Abravanel, Florence
Marion, Olivier
Couat, Chloe
Izopet, Jacques
Del Bello, Arnaud
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07) : 661 - 662
[4] COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
Ljungman, Per
de la Camara, Rafael
Mikulska, Malgorzata
Tridello, Gloria
Aguado, Beatriz
Al Zahrani, Mohsen
Apperley, Jane
Berceanu, Ana
Bofarull, Rodrigo Martino
Calbacho, Maria
Ciceri, Fabio
Lopez-Corral, Lucia
Crippa, Claudia
Fox, Maria Laura
Grassi, Anna
Jimenez, Maria-Jose
Demir, Safiye Koculu
Kwon, Mi
Llamas, Carlos Vallejo
Lorenzo, Jose Luis Lopez
Mielke, Stephan
Orchard, Kim
Porras, Rocio Parody
Vallisa, Daniele
Xhaard, Alienor
Knelange, Nina Simone
Cedillo, Angel
Kroger, Nicolaus
Pinana, Jose Luis
Styczynski, Jan
[J]. LEUKEMIA, 2021, 35 (10) : 2885 - 2894
[5] Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study
Maneikis, Kazimieras
Sablauskas, Karolis
Ringeleviciute, Ugne
Vaitekenaite, Vilmante
Cekauskiene, Rita
Kryzauskaite, Lina
Naumovas, Daniel
Banys, Valdas
Peceliunas, Valdas
Beinortas, Tumas
Griskevicius, Laimonas
[J]. LANCET HAEMATOLOGY, 2021, 8 (08): : E583 - E592
[6] Peret J., 2021, PREC VACC COVID 19 M
[7] Antibody response after second BNT162b2 dose in allogeneic HSCT recipients
Redjoul, Rabah
Le Bouter, Anne
Beckerich, Florence
Fourati, Slim
Maury, Sebastien
[J]. LANCET, 2021, 398 (10297) : 298 - 299
[8] Antipneumococcal Seroprotection Years After Vaccination in Allogeneic Hematopoietic Cell Transplant Recipients
Robin, Christine
Bahuaud, Mathilde
Redjoul, Rabah
Jeljeli, Mohamed
Leclerc, Mathieu
Cabanne, Ludovic
Beckerich, Florence
Pautas, Cecile
Maury, Sebastien
Cordonnier, Catherine
[J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) : E301 - E307
[9] Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Sharma, Akshay
Bhatt, Neel S.
St Martin, Andrew
Abid, Muhammad Bilal
Bloomquist, Jenni
Chemaly, Roy F.
Dandoy, Christopher
Gauthier, Jordan
Gowda, Lohith
Perales, Miguel-Angel
Seropian, Stuart
Shaw, Bronwen E.
Tuschl, Eileen E.
Zeidan, Amer M.
Riches, Marcie L.
Shah, Gunjan L.
[J]. LANCET HAEMATOLOGY, 2021, 8 (03): : E185 - E193
[10] Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series
Werbel, William A.
Boyarsky, Brian J.
Ou, Michael T.
Massie, Allan B.
Tobian, Aaron A. R.
Garonzik-Wang, Jacqueline M.
Segev, Dorry L.
[J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (09) : 1330 - +

← 1 →